Small study explores how IBD patients and doctors choose telemonitoring

NCT ID NCT07155486

Completed Knowledge-focused Sponsor: Franciscus Gasthuis Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study interviewed 10 IBD patients and 6 healthcare professionals to understand how they make shared decisions about using telemonitoring versus standard care. The goal is to improve the decision-making process so patients feel more engaged and informed. The study did not test any treatment or device.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors and patients make better, more informed choices about using telemonitoring for IBD care.

What could go wrong

This is a small, completed interview study with only 17 participants, so findings may not apply to all IBD patients or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TELEMEDICINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inflammatory bowel disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IBD (INFLAMMATORY BOWEL DISEASE) SHARED DECISION-MAKING TELEMEDICINE TELEMONITORING

Contacts and locations

Show contact details

Locations

Franciscus

Rotterdam, 3045PM, Netherlands
Jeroen Bosch Ziekenhuis

's-Hertogenbosch, 5223GZ, Netherlands